Previous evidence hasrevealed that the calcium-binding protein S100β is characterized as a plasmabiomarker of blood–brain barrier dysfunction, and disturbance of theblood–brain barrier is now shown to be the main initial feature in thepathogenesis of SVD [21]. The gene discussed is S100B; the disease is snowflake vitreoretinal degeneration.